<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-title><trans-title-group xml:lang="ru"><trans-title>Физиотерапия, бальнеология и реабилитация</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1681-3456</issn><issn publication-format="electronic">2413-2969</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">43617</article-id><article-id pub-id-type="doi">10.18821/1681-3456-2018-17-3-162-164</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original studies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Influence of the intravenous laser therapy on ceruloplasmin serum concentration in patients with chronic hepatitis B</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние внутривенной лазеротерапии на уровень церулоплазмина в крови больных хроническим вирусным гепатитом B</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Skvortsov</surname><given-names>Vsevolod Vladimirovich</given-names></name><name xml:lang="ru"><surname>Скворцов</surname><given-names>Всеволод Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, DSc, Associate Professor, Department of propaedeutics of internal diseases, Volgograd State Medical University, Ministry of Healthcare of the Russian Federation</p></bio><bio xml:lang="ru"><p>д-р мед. наук, доцент, кафедра пропедевтики внутренних болезней ФГБОУ ВО «Волгоградский государственный медицинский университет» Минздрава России</p></bio><email>vskvortsov1@ya.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Leshina</surname><given-names>O. A.</given-names></name><name xml:lang="ru"><surname>Лешина</surname><given-names>О. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vskvortsov1@ya.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zaitsev</surname><given-names>V. G.</given-names></name><name xml:lang="ru"><surname>Зайцев</surname><given-names>В. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vskvortsov1@ya.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Volgograd State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Волгоградский государственный медицинский университет» Минздрава РФ</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Volgograd State Medical University</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Волгоградский государственный университет»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-05-15" publication-format="electronic"><day>15</day><month>05</month><year>2018</year></pub-date><volume>17</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>162</fpage><lpage>164</lpage><history><date date-type="received" iso-8601-date="2020-09-04"><day>04</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, ООО "Эко-Вектор"</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://rjpbr.com/1681-3456/article/view/43617">https://rjpbr.com/1681-3456/article/view/43617</self-uri><abstract xml:lang="en"><p>Рatients with chronic hepatitis B were treated with the intravenouse red lasertherapy. Levels of ceruloplasmin, bilirubin, transaminazes, lipid peroxidation and antioxidative enzymes activity, intrahepatic hemodynamics were determined before and after therapy course. Treatment revealed correction of all indexes, improvement of general conditions after therapy course. Thus, intravenouse red lasertherapy is an effective non-drug method for treatment of chronic diffuse liver diseases.</p></abstract><trans-abstract xml:lang="ru"><p>У 50 пациентов хроническим вирусным гепатитом В до и после монотерапии внутривенным лазерным облучением крови исследовали уровень церулоплазмина в сыворотке крови, ферментов антиоксидантной системы, показателей цитолитического и мезенхимально-воспалительного синдромов, состояние перекисного окисления липидов. После лечения выявлено улучшение всех параметров, включая уровень церулоплазмина и субьективное состояние пациента.</p></trans-abstract><kwd-group xml:lang="en"><kwd>chronic hepatitis B</kwd><kwd>lipid peroxidation, cytolysis</kwd><kwd>ceruloplasmin, intravenouse red lasertherapy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>церулоплазмин</kwd><kwd>перекисное окисление липидов</kwd><kwd>цитолиз</kwd><kwd>хронический гепатит В</kwd><kwd>внутривенное лазерное облучение крови</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Sherlock S., Dooley J. Diseases of the liver and biliary tract. Moscow, 2002. 864 p.</mixed-citation><mixed-citation xml:lang="ru">Шерлок Ш., Дули Дж. Заболевания печени и желчных путей. М., 2002. 864 с.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Mzhelskaya T.I. Factors affecting the concentration of serum ceruloplasmin in Wilson's disease: features of the central nervous system. Neurochemistry. 2000; (3): 231–6.</mixed-citation><mixed-citation xml:lang="ru">Мжельская Т.И. Факторы, влияющие на концентрацию сывороточного церулоплазмина при болезни Вильсона: особенности поражения центральной нервной системы. Нейрохимия. 2000; (3): 231-6.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Shevchenko O.P., Shumakov D.V., Kiladze E.S. et al. Systemic inflammatory response during surgery under artificial blood circulation: CRP, ceruloplasmin and haptoglobin in IHD patients after coronary artery bypass surgery. Vestnik transplantologii i iskusstvennykh organov. 2001; (1): 26–31.</mixed-citation><mixed-citation xml:lang="ru">Шевченко О.П., Шумаков Д.В., Киладзе Е.С. и др. Системный воспалительный ответ при операции в условиях искусственного кровообращения: СРБ, церулоплазмин и гаптоглобин у больных ИБС после аортокоронарного шунтирования. Вестник трансплантологии и искусственных органов. 2001; (1): 26–31.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><mixed-citation>Aisen P., Morell A.G., Alpert S., Sternlieb I. Biliary excretion of caeruloplasmin copper. Nature. 1964; 203(4947): 873–4.</mixed-citation></ref></ref-list></back></article>
